Bontemps, Andrew P and Hawes, Elizabeth S and Pridgen, Bailey E and Wagner, William P and Black, Dominique and Cropsey, Karen L (2026) Cannabis use within the United States: prevalence of cannabis use by state legal status and perceptions of benefit and harm. Drug and Alcohol Dependence Reports , 19 .

Graham, Myfanwy and Assefa, Dereje and Cong-Lem, Ngo and Nielsen, Suzanne (2026) Higher THC concentration medicinal cannabis products efficacy and safety considerations: a rapid review. Drug and Alcohol Review , 45 , (4) .

[Oireachtas] Dáil Éireann debate. Question 447, 448, 449 – Customs and excise [Tobacco] [28732/26, 28733/26, 28735/26]. (21 Apr 2026)

Trice, Catharine and Prebihalo, Sarah and Rattan, Saniya and Spencer, Kara and Karasick, Andrew and Scott-Richardson, Maya and Punzalan, Cecile and Gensheimer, Kathleen and Markon, André and South, Erin M and Bersoff-Matcha, Susan and Vasisht, Kaveeta and Wolpert, Beverly J (2026) Cannabinoid use among adult women: a scoping review. Journal of Women's Health , 35 , (3) , pp. 271-289.

Dillon, Lucy (2026) The 68th session of the Commission on Narcotic Drugs. Drugnet Ireland , Issue 93, February 2026 , pp. 12-13.

Metrik, Jane and Aston, Elizabeth R and Gunn, Rachel L and Swift, Robert and MacKillop, James and Kahler, Christopher W (2026) Acute effects of cannabis on alcohol craving and consumption: a randomized controlled crossover trial. The American Journal of Psychiatry , 183 , (2) , pp. 134-143.

Central Intelligence Agency. (2026) The world factbook. Field listing: illicit drugs. URL: https://www.cia.gov/the-world-factbook/field/illic...

Metrik, Jane and Bush, Nicholas and Gunn, Rachel L and McCarthy, Denis M (2026) Recent advances in the science of cannabis-impaired driving. Current Addiction Reports , 13 .

Uporova, Julia and Peacock, Amy and Sutherland, Rachel (2026) Prescribed cannabis and driving behaviours among two samples of people who regularly use illicit drugs, 2025. Sydney: National Drug and Alcohol Research Centre, UNSW Sydney.

Ateş, Gülay and Welsch, Patrick and Klose, Petra and Phillips, Tudor and Lambers, Britta and Häuser, Winfried and Radbruch, Lukas (2026) Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews , 1 , (1) .

Lees Thorne, Rachel and Lawn, Will and Petrilli, Kat and Trinci, Katie and Borissova, Anya and Ofori, Shelan and Mokrysz, Claire and Curran, H Valerie and Hines, Lindsey A and Freeman, Tom P (2026) Estimating thresholds for risk of cannabis use disorder using standard delta-9-tetrahydrocannabinol (THC) units. Addiction , Early online .

Canadian Centre on Substance Use and Addiction. (2026) Addressing cannabis hyperemesis syndrome in Canada. Ottawa: Canadian Centre on Substance Use and Addiction.

McDonald, André J and Doggett, Amanda and Bondy, Susan J and Colman, Ian and Cook, Steven and Hamilton, Hayley A and Kurdyak, Paul and Leatherdale, Scott T and Myran, Daniel T and Rehm, Jürgen and Wickens, Christine M and MacKillop, James and Halladay, Jillian (2026) Adolescent cannabis use and psychological distress from 2013 to 2023: a population-based study in Ontario, Canada. Addiction , 121 , (6) , pp. 1495-1507.

Medical Bureau of Road Safety. (2025) Medical Bureau of Road Safety annual report 2024. Dublin: Medical Bureau of Road Safety.

Wilkinson, Emma (2025) The rise of nitazenes: what pharmacists need to know. The Pharmacist .

[Oireachtas] Dáil Éireann Debate. Question 389 – Customs and excise [vape products] [61349/25]. (12 Nov 2025)

Oz, Esin and Kasikci, Merve and Celik, İbrahim and Gurler, Mukaddes (2025) Metabolic profile of male cannabis users and estimation of candidate biomarkers. Chemical Research in Toxicology , 38 , (10) , pp. 1762-1770.

Spinazzola, Edoardo and Degen, Hannah and Austin-Zimmerman, Isabelle and Trotta, Giulia and Chesney, Edward and Li, Zhikun and Alameda, Luis and Leung, Bok Man and Lang, Yifei and Quattrone, Andrea and Quattrone, Diego and Castrignanò, Erika and Wolff, Kim and Murray, Robin and Freeman, Tom P and Di Forti, Marta (2025) Are reasons for first using cannabis associated with subsequent cannabis consumption (standard THC units) and psychopathology? BMJ Mental Health , 28 .

Li, Sophie and Solmi, Marco and Myran, Daniel T and Fabiano, Nicholas (2025) Cannabis and psychosis. Canadian Medical Association Journal , 197 , (27) .

Trotta, Giulia and Spinazzola, Edoardo and Degen, Hannah and Li, Zhikun and Austin-Zimmerman, Isabelle and Leung, Bok Man and Lang, Yifei and Rodriguez, Victoria and Aas, Monica and Sideli, Lucia and Wolff, Kim and Freeman, Tom P and Murray, Robin M and Wong, Chloe C Y and Alameda, Luis and Di Forti, Marta (2025) The impact of childhood trauma and cannabis use on paranoia: a structural equation model approach. Psychological Medicine , 55 .

[Oireachtas] Dáil Éireann debate. Question 2604 – Departmental regulations [THC products] [41090/25]. (29 Jul 2025)

Dooley, Aileen (2025) HSE drugs and alcohol helpline and the HSE HIV and sexual health helpline annual report 2024. Dublin: Health Service Executive.

European Union Drugs Agency. (2025) European drug report 2025: trends and developments. Lisbon: European Union Drugs Agency.

National Drug and Alcohol Research Centre. (2025) NDARC fact sheet: cannabis. Sydney: National Drug and Alcohol Research Centre.

Lees, Rachel and Lawn, Will and Petrilli, Kat and Brown, Amelia and Trinci, Katie and Borissova, Anya and Ofori, Shelan and Mokrysz, Claire and Curran, H Valerie and Hines, Lindsey A and Freeman, Tom P (2025) Persistent increased severity of cannabis use disorder symptoms in adolescents compared to adults: a one-year longitudinal study. European Archives of Psychiatry and Clinical Neuroscience , 275 , pp. 397-406.

Advisory Council on the Misuse of Drugs. (2025) ‘Semi-synthetic’ cannabinoids: cannabinoids related to tetrahydro- cannabinol and cannabidiol. London: Advisory Council on the Misuse of Drugs.

Shafie, Mahan and Ing, Kevin and Rostam-Abadi, Yasna and Weleff, Jeremy and Griffin, Mackenzie and Ranganathan, Mohini and Mohammad Aghaei, Ardavan and Pratt, Nicholas and Funaro, Melissa C and Bassir Nia, Anahita (2025) The potential use of cannabidiol in the treatment of opioid use disorder: a systematic review. Addiction Biology , 30 , (5) .

[Oireachtas] Dáil Éireann debate. Questions 341, 691 – Cannabis for medicinal use [Cannabinoids] [16274/25, 15652/25]. (02 Apr 2025)

de Bode, Nora and Kroon, Emese and Sznitman, Sharon R and Cousijn, Janna (2025) The differential effects of medicinal cannabis on mental health: a systematic review. Clinical Psychology Review , 118 .

[Irish Times] , Bowers, Shauna Teens presenting at EDs with psychosis from legal, semi-synthentic cannabis product, says leading psychiatrist. (26 Mar 2025)

Millar, Seán (2025) Psychotic illness triggered by widely available semi-synthetic cannabinoid. Drugnet Ireland , Issue 90, Winter 2025 , p. 15.

Pourebrahim, Sepehr and Ahmad, Tooba and Rottmann, Elisabeth and Schulze, Johannes and Scheller, Bertram (2025) Does cannabis use contribute to schizophrenia? A causation analysis based on epidemiological evidence. Biomolecules , 15 , (3) .

Arlen, Maddison T and Patterson, Stephanie J and Page, Michelle K and Liu, Rui and Caruana, Vincenza and Wilson, Emily T and Laporte, Stéphane A and Goniewicz, Maciej L and Harris, Cory S and Eidelman, David H and Baglole, Carolyn J (2025) Cannabis vaping elicits transcriptomic and metabolomic changes involved in inflammatory, oxidative stress, and cancer pathways in human bronchial epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology , 328 , (3) , L478-L496.

Gardner, Matthew and Bowden, Celeste and Manzoor, Shoaib and Cozier, Gyles E and Andrews, Rachael C and Craft, Sam and Skumlien, Martine and Sunderland, Peter and Tooth, Tom and Collins, Peter and Power, Alexander and Haines, Tom SF and Freeman, Tom P and Scott, Jennifer and Sutcliffe, Oliver B and Bowman, Richard W and Husbands, Stephen M and Pudney, Christopher R (2025) Field-portable device for detection of controlled and psychoactive substances from e-cigarettes. ACS Omega , 10 , (8) , pp. 7839-7847.

Albrecht, Matthew A and Hasan, Razi and Kekez, Damir and Zhou, Huaqiong (2025) Dose-response relationship between blood concentrations of THC and crash culpability risk: an updated meta-regression of culpability studies. Drug Science, Policy and Law , 11 .

[Oireachtas] Dáil Éireann debate. Question 220, 205 – Healthcare policy [3906/25] Agriculture industry [Hemp] [3907/25]. (06 Feb 2025)

European Union Drugs Agency. (2025) Synthetic cannabinoids. URL: https://www.euda.europa.eu/topics/synthetic-cannab...

Chesney, Edward and Oliver, Dominic and Sarma, Ananya and Lamper, Ayşe Doğa and Slimani, Ikram and Lloyd, Millie and Dickens, Alex M and Welds, Michael and Kråkström, Matilda and Gasparini-Andre, Irma and Orešič, Matej and Lawn, Will and Babayeva, Natavan and Freeman, Tom P and Englund, Amir and Strang, John and McGuire, Philip (2025) Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial. Neuropsychopharmacology , 50 , pp. 1759-1767.

Hessler, Meaghan R and Kacinko, Sherri L and Logan, Barry K (2025) Drug-facilitated crime: a review of findings between 2019 and 2023. Journal of Forensic Sciences , 70 , (6) , pp. 2442-2464.

The State Laboratory. (2025) The State Laboratory annual report 2024. Dublin: The State Laboratory.

Burmeister, James R and Jung, John K (2025) High risk, low key: the new face of drug use. Substance Use : Research and Treatment , 19 .

Cammà, Guido and Verdouw, Monika P and van der Meer, Pim B and Groenink, Lucianne and Batalla, Albert (2024) Therapeutic potential of minor cannabinoids in psychiatric disorders: a systematic review. European Neuropsychopharmacology , 91 , pp. 9-24.

Medical Bureau of Road Safety. (2024) Medical Bureau of Road Safety annual report 2023. Dublin: Medical Bureau of Road Safety.

The State Laboratory. (2024) The State Laboratory annual report 2023. Dublin: The State Laboratory.

Granville, Ashely and Grigg, Jodie and Kowalski, Michala and Sevigny, Eric and Zobel, Frank and Fortin, Davide (2024) What can we learn from low-THC cannabis growers in Europe? A comparative transnational study of small-scale cannabis growers from Italy and Switzerland. International Journal of Drug Policy , 144 , (3) .

Society for the Study of Addiction. Calder, Robert (2024) Addiction audio. Season 2, 2024. London: Society for the Study of Addiction.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2024) EU drug market: New psychoactive substances — Distribution and supply in Europe: semi-synthetic cannabinoids. URL: https://www.euda.europa.eu/publications/eu-drug-ma...

Wood, Shea and Gabrys, Robert (2024) A standard THC unit in Canada. Recommendations for implementation. Ottawa: Canadian Centre on Substance Use and Addiction.

Public Health Scotland. (2024) Scotland. Public health alert: Xylazine – newly detected drug. Edinburgh: Public Health Scotland.

[Oireachtas] Joint Committee on Health debate. Implementation of Slaintecare reforms: Department of Health and HSE [Medicinal cannabis]. (08 May 2024)

Crew. (2024) THC vapes. Edinburgh: CREW.

Health Products Regulatory Authority. [HPRA] European Commission consultation on cannabidiol (CBD) used in cosmetic products. (06 Mar 2024)

Harries, Richard L and Norman, Caitlyn and Reid, Robert and NicDaéid, Niamh and Nisbet, Lorna A (2024) Detection of anabolic-androgenic steroids in e-cigarettes seized from prisons: a case study. Forensic Science International , 356 .

Lambe, Kathryn (2024) Review of efficacy and safety of medicinal cannabis, 2024. Drugnet Ireland , Issue 87, Winter 2024 , pp. 12-13.

[Oireachtas] Dáil Éireann debate. Question 1592 – Healthcare policy [MCAP] [57098/23]. (17 Jan 2024)

Di Ciano, Patricia and Rajji, Tarek K and Hong, Lauren and Zhao, Sampson and Byrne, Patrick and Elzohairy, Yoassry and Brubacher, Jeffrey R and McGrath, Michael and Brands, Bruna and Chen, Sheng and Wang, Wei and Hasan, Omer S M and Wickens, Christine M and Kaduri, Pamela and Le Foll, Bernard (2024) Cannabis and driving in older adults. JAMA Network Open , 7 , (1) .

Lambe, Kathryn and Teahan, Áine and Lee, Caitriona and fitzpatrick, John-Mark and Cagney, Olivia and Patje, Darren and Long, Jean (2024) The efficacy and safety of medicinal cannabis in adult populations: an evidence review. Dublin: Health Research Board.

Oliver, Dominic and Englund, Amir and Chesney, Edward and Chester, Lucy and Wilson, Jack and Sovi, Simina and Wigroth, Stina and Hodsoll, John and Strang, John and Murray, Robin M and Freeman, Tom P and Fusar-Poli, Paolo and McGuire, Philip (2024) Cannabidiol does not attenuate acute delta-9-tetrahydrocannabinol-induced attentional bias in healthy volunteers: a randomised, double-blind, cross-over study. Addiction , 119 , (2) , pp. 322-333.

Metrik, Jane and McCarthy, Denis M (2024) Editorial: how research and policy can shape driving under the influence of cannabis. Addiction , 119 , (2) , pp. 208-210.

Copeland, Caroline S and Rice, Kathleen and Rock, Kirsten L and Hudson, Simon and Streete, Peter and Lawson, Alexander J and Couchman, Lewis and Holland, Adam and Morley, Stephen (2024) Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug-testing and law enforcement. Addiction , 119 , (7) , pp. 1301-1309.

Zhang, Grace Y and Incze, Michael A (2024) I am curious about cannabis edibles - what should I know? JAMA Internal Medicine , 184 , (10) .

Schoeler, Tabea and Baldwin, Jessie R and Martin, Ellen and Barkhuizen, Wikus and Pingault, Jean-Baptiste (2024) Assessing rates and predictors of cannabis-associated psychotic symptoms across observational, experimental and medical research. Nature Mental Health , 2 , pp. 865-876.

Smith, Gary A and Burgess, Alice and Badeti, Jaahnavi and Rine, Natalie I and Gaw, Christopher E and Middelberg, Leah K and Spiller, Henry A and Hays, Hannah L (2024) Delta-8 tetrahydrocannabinol exposures reported to US poison centers: variations among US states and regions and associations with public policy. Journal of Medical Toxicology , 20 , pp. 389-400.

European Monitoring Centre for Drugs and Drug Addiction, Europol. (2023) EU drug market: cannabis — in-depth analysis. URL: https://www.euda.europa.eu/publications/eu-drug-ma...

Institute of Alcohol Studies. (2023) Cannabis liberalisation: lessons for alcohol policy. London: Institute of Alcohol Studies.

Tort, Sera and Husein-ElAhmed, Husein (2023) Clinical question: For adults with opioid‐refractory cancer pain, what are the benefits and harms of nabiximols (tetrahydrocannabinol (THC) and cannabidiol (CBD))? Cochrane Clinical Answers .

[Oireachtas] Dáil Éireann debate. Questions 236 - Health Service Executive [Cannabinoids in vapes] [34427/23]. (12 Jul 2023)

Gaines Buchler, Emily (2023) The science and safety of recreational marijuana. John Hopkins University Hub .

[Oireachtas] Dáil Éireann debate. Question 73 - Cannabis for medicinal use [28659/23]. (14 Jun 2023)

Lin, Lin and Jung, Kwang-Mook and Lee, Hye-Lim and Le, Johnny and Colleluori, Georgia and Wood, Courtney and Palese, Francesca and Squire, Erica and Ramirez, Jade and Su, Shiqi and Torrens, Alexa and Fotio, Yannick and Tang, Lingyi and Yu, Clinton and Yang, Qin and Huang, Lan and DiPatrizio, Nicholas and Jang, Cholsoon and Cinti, Saverio and Piomelli, Daniele (2023) Adolescent exposure to low-dose THC disrupts energy balance and adipose organ homeostasis in adulthood. Cell Metabolism .

[Oireachtas] Dáil Éireann debate. Written answer 214 - Revenue Commissioners (cannabinoids / cannabis edibles) [25751/23]. (30 May 2023)

European Monitoring Centre for Drugs and Drug Addiction. Ujváry, István and Evans-Brown, Michael and Gallegos, Ana and Planchuelo, Gregorio and de Morais, Joanna and Christie, Rachel and Jorge, Rita and Sedefov, Roumen (2023) Hexahydrocannabinol (HHC) and related substances. Technical report. Luxembourg: Office for Official Publications of the European Communities.

Manthey, Jakob and Hayer, Tobias and Jacobsen, Britta and Kalke, Jens and Klinger, Sinja and Rehm, Jürgen and Rosenkranz, Moritz and Verthein, Uwe and Wirth, Marielle and Armstrong, Michael and Myran, Daniel T and Pacula, Rosalie and Queirolo, Rosario and Zobel, Frank (2023) Effects of legalizing cannabis. Technical report. Hamburg: “Institut für interdisziplinäre Sucht- und Drogenforschung (ISD).

[Oireachtas] Dáil Éireann Debate. Written answer 1474 – Cannabis for medical use [13710/23]. (21 Mar 2023)

Brubacher, J R and Chan, H and Erdelyi, S and Yuan, Y and Daoust, R and Vaillancourt, C and Rowe, B and Lee, J and Mercier, E and Atkinson, P and Davis, P and Clarke, D and Taylor, J and Macpherson, A and Emond, M and Al-Hakim, D and Horwood, C and Wishart, I and Magee, K and Rao, J and Eppler, J (2023) High-'n'-dry? A comparison of cannabis and alcohol use in drivers presenting to hospital after a vehicular collision. Addiction , 118 , (8) , pp. 1507-1516.

Hasbi, Ahmed and Madras, Bertha K and George, Susan R (2023) Endocannabinoid system and exogenous cannabinoids in depression and anxiety: a review. Brain Sciences , 13 , (2) .

Eymery, Mathias C and McCarthy, Andrew A and Hausmann, Jens (2023) Linking medicinal cannabis to autotaxin–lysophosphatidic acid signaling. Life Science Alliance , 6 , (2) .

Lorenzetti, Valentina and Gaillard, Alexandra and Thomson, Diny and Englund, Amir and Freeman, Tom P (2023) Effects of cannabinoids on resting state functional brain connectivity: a systematic review. Neuroscience and Biobehavioral Reviews , 145 .

[HSE drugs.ie] HSE Drug Trend Risk Communication on cannabis jellies adulterated with synthetic cannabinoids. (06 Jan 2023)

Englund, Amir and Oliver, Dominic and Chesney, Edward and Chester, Lucy and Wilson, Jack and Sovi, Simina and De Micheli, Andrea and Hodsoll, John and Fusar-Poli, Paolo and Strang, John and Murray, Robin M and Freeman, Tom P and McGuire, Philip (2023) Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios. Neuropsychopharmacology , 48 , pp. 869-876.

Hall, Wayne and Leung, Janni and Carlini, Beatriz H (2023) How should policy makers regulate the tetrahydrocannabinol content of cannabis products in a legal market? Addiction , 118 , (6) , pp. 998-1003.

Lawn, Will and Trinci, Katie and Mokrysz, Claire and Borissova, Anna and Ofori, Shelan and Petrilli, Kat and Bloomfield, Michael and Haniff, Zarah R and Hall, Daniel and Fernandez-Vinson, Natalia and Wang, Simiao and Englund, Amir and Chesney, Edward and Wall, Matthew B and Freeman, Tom P and Curran, H Valerie (2023) The acute effects of cannabis with and without cannabidiol in adults and adolescents: a randomised, double-blind, placebo-controlled, crossover experiment. Addiction , 118 , (7) , pp. 1282-1294.

Puljević, Cheneal and Cossart, Amelia and Davies, Emma L and Barratt, Monica J and Maier, Larissa J and Jauffret-Roustide, Marie and Winstock, Adam R and Ferris, Jason A (2023) Shifts in cannabis use at the onset of the COVID-19 pandemic among Global Drug Survey respondents from 13 countries. Drugs, Habits and Social Policy , 24 , (3) , pp. 145-161.

Fischer, Benedikt and Hall, Wayne and Fidalgo, Thiago M and Hoch, Eva and Foll, Bernard Le and Medina-Mora, Maria-Elena and Reimer, Jens and Tibbo, Philip G and Jutras-Aswad, Didier (2023) Recommendations for reducing the risk of cannabis use-related adverse psychosis outcomes: a public mental health-oriented evidence review. Journal of Dual Diagnosis , 19 , (2-3) , pp. 71-96.

McCartney, Danielle and Suraev, Anastasia and McGregor, Iain S (2023) The "next day" effects of cannabis use: a systematic review. Cannabis and Cannabinoid Research , 8 , (1) , pp. 92-114.

Borissova, Anya and Curmi, Alex (2022) Maudsley Learning Podcast. Interview #42: More about cannabis (with Professor Valerie Curran and Dr Will Lawn). London: Maudsley Learning Podcast.

[thejournal.ie] , O'Faolain, Aodhan Court dismisses challenge to ban on selling products containing THC. (09 Nov 2022)

Millar, Sean (2022) Irish findings from the European Web Survey on Drugs. Drugnet Ireland , Issue 83, Winter 2022 , pp. 1-5.

Karoly, Hollis C and Prince, Mark A and Emery, Noah N and Smith, Emma E and Piercey, Cianna J and Conner, Bradley T (2022) Protocol for a mobile laboratory study of co-administration of cannabis concentrates with a standard alcohol dose in humans. PLoS ONE , 17 , (11) .

Matheson, Justin and Bourgault, Zoe and Le Foll, Bernard (2022) Sex differences in the neuropsychiatric effects and pharmacokinetics of cannabidiol: a scoping review. Biomolecules , 12 , (10) .

National Forensic Laboratory Information System. (2022) NFLIS-Drug 2021 annual report. U.S. Drug Enforcement Administration, Diversion Control Division.

Gunasekera, Brandon and Davies, Cathy and Blest-Hopley, Grace and Veronese, Mattia and Ramsey, Nick F and Bossong, Matthijs G and Radua, Joaquim and Bhattacharyya, Sagnik (2022) Task-independent acute effects of delta-9-tetrahydrocannabinol on human brain function and its relationship with cannabinoid receptor gene expression: a neuroimaging meta-regression analysis. Neuroscience and Biobehavioral Reviews , 140 .

Galvin, Brian (2022) European Drug Report, 2022. Drugnet Ireland , Issue 82, Summer 2022 , pp. 25-26.

Ontario Agency for Health Protection and Promotion (Public Health Ontario). (2022) Scan of evidence and jurisdictional approaches to the decriminalization of drugs. Toronto: King’s Printer for Ontario.

Kritikos, Alexandra F and Pacula, Rosalie Liccardo (2022) Characterization of cannabis products purchased for medical use in New York state. JAMA Network Open , 5 , (8) .

Royal College of Psychiatrists. (2022) Cannabis and mental health: information for young people. URL: https://www.rcpsych.ac.uk/mental-health/parents-an...

Breit, Kristen R and Rodriguez, Cristina G and Lei, Annie and Hussain, Samirah and Thomas, Jennifer D (2022) Effects of prenatal alcohol and delta-9-tetrahydrocannabinol exposure via electronic cigarettes on motor development. Alcoholism, Clinical and Experimental Research , 46 , (8) , pp. 1408-1422.

Food Safety Authority of Ireland. Recall of certain batches of CBD and hemp oil products due to the presence of unsafe levels of delta‐9‐tetrahydrocannabinol (THC). (14 Jul 2022)

Munger, Kaelas R and Jensen, Robert P and Strongin, Robert M (2022) Vaping cannabinoid acetates leads to ketene formation. Chemical Research in Toxicology , (Working paper) .

Spindle, Tory R and Sholler, Dennis J and Cone, Edward J and Murphy, Timothy P and ElSohly, Mahmoud and Winecker, Ruth E and Flegel, Ronald R and Bonn-Miller, Marcel O and Vandrey, Ryan (2022) Cannabinoid content and label accuracy of hemp-derived topical products available online and at national retail stores. JAMA Network Open , 5 , (7) .

Liccardo Pacula, Rosalie and Pessar, Seema Choksy and Zhu, Joy and Kritikos, Alexandra F and Smart, Rosanna (2022) Federal regulations of cannabis for public health in the United States. Los Angelus: USC Schaeffer.

[Health Research Board] European drug report 2022. HRB press release. (14 Jun 2022)

[Oireachtas] Dáil Éireann Debate. Written answer 80 – Medicinal products [26940/22] [medical cannabis]. (26 May 2022)

[Oireachtas] Dáil Éireann Debate. Written answer 697 – Cannabis for medical use [26559/22]. (24 May 2022)

Wurz, Gregory T and DeGregorio, Michael W (2022) Indeterminacy of cannabis impairment and ∆-tetrahydrocannabinol (∆-THC) levels in blood and breath. Scientific Reports , 12 .

Edinoff, Amber N and Fort, Juliana M and Singh, Christina and Wagner, Sarah E and Rodriguez, Jessica R and Johnson, Catherine A and Cornett, Elyse M and Murnane, Kevin S and Kaye, Adam M and Kaye, Alan D (2022) Alternative options for complex, recurrent pain states using cannabinoids, psilocybin, and ketamine: a narrative review of clinical evidence. Neurology International , 14 , (2) , pp. 423-436.

[Oireachtas] Joint Committee on Agriculture, Food and the Marine debate. Hemp industry: discussion. (27 Apr 2022)

Gross, Marielle S and Le Neveu, Margot and Milliken, Kara A and Beach, Mary Catherine (2022) Patient caught breastfeeding and instructed to stop: an empirical ethics study on marijuana and lactation. Journal of Cannabis Research , 4 .

Goodman, Samantha and Hammond, David (2022) THC labeling on cannabis products: an experimental study of approaches for labeling THC servings on cannabis edibles. Journal of Cannabis Research , 4 .

HSE drugs.ie. (2022) Cannabis edible products. Dublin: HSE drugs.ie.

Hemp Federation Ireland. (2022) EU Commission clarifies the legality of THC in hemp food. Dublin: Hemp Federation Ireland.

James, Tameika R and Richards, Andrea A and Lowe, Dwight A and Reid, Walton A and Watson, Charah T and Pepple, Dagogo J (2022) The in vitro effect of delta-9-tetrahydrocannabinol and cannabidiol on whole blood viscosity, elasticity and membrane integrity. Journal of Cannabis Research , 4 .

Berberian, S and Broussard, M L and Tully, C and Methuku, V and Pardini, D A and Meier, M H (2022) Young adults' familiarity with different cannabis product terms: the need for standardized cannabis surveys. Journal of Cannabis Research , 4 .

[Oireachtas] Dáil Éireann debate. Written answer 225 – Cannabis for medicinal use [travel] [13439/22]. (09 Mar 2022)

Fearby, Nathan and Penman, Samantha and Thanos, Panayotis (2022) Effects of Δ9-Tetrahydrocannibinol (THC) on obesity at different stages of life: a literature review. International Journal of Environmental Research and Public Health , 19 , (6) .

[Oireachtas] Joint Committee on Agriculture, Food and the Marine debate. Development of the hemp sector in Ireland: discussion. (23 Feb 2022)

[Food Safety Authority of Ireland] Recall of certain batches of Kama Hemp Kama artisan coffee due to the presence of unsafe levels of Delta‐9‐tetrahydrocannabinol (THC). (20 Jan 2022)

Ganesh, Suhas and D'Souza, Deepak Cyril (2022) Cannabis and psychosis: recent epidemiological findings continuing the "causality debate'. The American Journal of Psychiatry , 179 , (1) , pp. 8-10.

Connor, Jason P and Stjepanović, Daniel and Budney, Alan J and Le Foll, Bernard and Hall, Wayne D (2022) Clinical management of cannabis withdrawal. Addiction , 117 , (7) , pp. 2075-2095.

Marcotte, Thomas D and Umlauf, Anya and Grelotti, David J and Sones, Emily G and Sobolesky, Philip M and Smith, Breland E and Hoffman, Melissa A and Hubbard, Jacqueline A and Severson, Joan and Huestis, Marilyn A and Grant, Igor and Fitzgerald, Robert L (2022) Driving performance and cannabis users' perception of safety: a randomized clinical trial. JAMA Psychiatry , 79 , (3) , pp. 201-209.

Procaccia, Shiri and Moshe Lewitus, Gil and Lipson, Carni and Shapira, Anna and Berman, Paula and Meiri, David (2022) Cannabis for medical use: versatile plant rather than a single drug. Frontiers in Pharmacology , 12 .

McDonagh, Marian S and Morasco, Benjamin J and Wagner, Jesse and Ahmed, Azrah Y and Fu, Rongwei and Kansagara, Devan and Chou, Roger (2022) Cannabis-based products for chronic pain: a systematic review. Annals of Internal Medicine , 175 , pp. 1143-1153.

Breit, Kristen R and Rodriguez, Cristina G and Lei, Annie and Hussain, Samirah and Thomas, Jennifer D (2022) Effects of prenatal alcohol and delta-9-tetrahydrocannabinol exposure via electronic cigarettes on motor development. Alcoholism, Clinical and Experimental Research , 46 , (8) , pp. 1408-1422.

Boakye, Ellen and El Shahawy, Omar and Obisesan, Olufunmilayo and Dzaye, Omar and Osei, Albert D and Erhabor, John and Uddin, S M Iftekhar and Blaha, Michael J (2022) The inverse association of state cannabis vaping prevalence with the e-cigarette or vaping product-use associated lung injury. PLoS ONE , 17 , (10) .

[Food Safety Authority of Ireland] FSAI calls for vigilance to dangers of jelly sweets containing cannabis in run up to Halloween. (20 Oct 2021)

[Irish Examiner] , O'Rourke, Ryan Warnings over dangers of 'fake' THC edibles. (04 Oct 2021)

[Oireachtas] Joint Committee on Health debate. Medical Cannabis Access Programme Update: Discussion. (29 Sep 2021)

Farrelly, Aaron Mark and Vlachou, Styliani (2021) Effects of cannabinoid exposure during neurodevelopment on future effects of drugs of abuse: a preclinical perspective. International Journal of Molecular Sciences , 22 , (18) .

Manthey, Jakob and Freeman, Tom P and Kilian, Carolin and López-Pelayo, Hugo and Rehm, Jürgen (2021) Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates. The Lancet Regional Health - Europe , 10 , (100227) .

[Food Safety Authority of Ireland] Recall of various CBD food supplements due to the presence of unsafe levels of delta‐9‐tetrahydrocannabinol (THC). (27 Jul 2021)

Kuzma-Hunt, Alexander G and Truong, Vivien B and Favetta, Laura A (2021) Glucocorticoids, stress and delta-9 tetrahydrocannabinol (THC) during early embryonic development. International Journal of Molecular Sciences , 22 , (14) .

Gullo, Matthew J and Papinczak, Zoë E and Feeney, Gerald F X and Young, Ross McD and Connor, Jason P (2021) Precision mental health care for cannabis use disorder: utility of a bioSocial Cognitive Theory to inform treatment. Frontiers in Psychiatry , 12 , p. 643107.

Correlation – European Harm Reduction Network. (2021) Cannabis Quick Tests and synthetic cannabinoids. Amsterdam: Correlation – European Harm Reduction Network.

[Independent.ie] , Bracken, Ali Cannabis edibles: Dublin principals warn parents that THC jellies are being sold in some schools. (13 Jun 2021)

Dilley, Julia A and Graves, Janessa M and Brooks-Russell, Ashley and Whitehill, Jennifer M and Liebelt, Erica L (2021) Trends and characteristics of manufactured cannabis product and cannabis plant product exposures reported to US poison control centers, 2017-2019. JAMA Network Open , 4 , (5) , e2110925.

Freeman, Tom P and Craft, Sam and Wilson, Jack and Stylianou, Stephan and ElSohly, Mahmoud and Di Forti, Marta and Lynskey, Michael T (2021) Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis. Addiction , 116 , (5) , pp. 1000-1010.

[Food Safety Authority of Ireland] FSAI issues warning on edible products (sweets) containing cannabis. (26 Apr 2021)

Farrelly, Aaron M and Vlachou, Styliani and Grintzalis, Konstantinos (2021) Efficacy of phytocannabinoids in epilepsy treatment: novel approaches and recent advances. International Journal of Environmental Research and Public Health , 18 , (8) .

Gilman, Jodi M and Schmitt, William A and Wheeler, Grace and Schuster, Randi M and Klawitter, Jost and Sempio, Cristina and Evins, A Eden (2021) Research letter: Variation in cannabinoid metabolites present in the urine of adults using medical cannabis products in Massachusetts. JAMA Network Open , 4 , (4) , e215490.

Krishnan, Aditya and Chizo Agwu, Juliana and Kallappa, Chetana and Pandey, Ragesh (2021) Case report. Development of central precocious puberty following cannabinoid use for paediatric epilepsy: causal or coincidence? BMJ Case Reports , 14 , e239678.

Morie, Kristen P and Potenza, Marc N (2021) A mini-review of relationships between cannabis use and neural foundations of reward processing, inhibitory control and working memory. Frontiers in Psychiatry , 12 , p. 657371.

Oordt, Anouk and Eeuwijk, Jennifer and Bunge, Eveline and Wester, Valérie and Klein, Philip and Kanters, Tim and Uyl-de Groot, Carin (2021) Medical cannabis for treating various symptoms in Switzerland. Berne: Federal Office of Public Health.

National Institute for Health and Care Excellence. (2021) Cannabis-based medicinal products. London: NICE.

Velayudhan, Latha and McGoohan, Katie and Bhattacharyya, Sagnik (2021) Safety and tolerability of natural and synthetic cannabinoids in adults aged over 50 years: A systematic review and meta-analysis. PLoS Medicine , 18 , (3) , e1003524.

McCartney, Danielle and Arkell, Thomas R and Irwin, Christopher and McGregor, Iain S (2021) Determining the magnitude and duration of acute Δ-tetrahydrocannabinol (Δ-THC)-induced driving and cognitive impairment: a systematic and meta-analytic review. Neuroscience and Biobehavioral Reviews , 126 , pp. 175-193.

Leung, Janni and Stjepanović, Daniel and Dawson, Danielle and Hall, Wayne D (2021) Do cannabis users reduce their THC dosages when using more potent cannabis products? A review. Frontiers in Psychiatry , 12 , p. 630602.

Sorkhou, Maryam and Bedder, Rachel H and George, Tony P (2021) The behavioral sequelae of cannabis use in healthy people: a systematic review. Frontiers in Psychiatry , 12 .

European Monitoring Centre for Drugs and Drug Addiction. (2020) Low-THC cannabis products in Europe. Luxembourg: Publications Office of the European Union.

Department of Social Welfare, City of Zurich. Schori, Dominique (2020) C-EHRN briefing paper. Amsterdam: Correlation – European Harm Reduction Network.

Hall, Wayne and Leung, Janni and Lynskey, Michael (2020) The effects of cannabis use on the development of adolescents and young adults. Annual Review of Developmental Psychology , 2 , pp. 461-483.

Jones, Éamon and Vlachou, Styliani (2020) A critical review of the role of the cannabinoid compounds Δ-tetrahydrocannabinol (Δ-THC) and cannabidiol (CBD) and their combination in multiple sclerosis treatment. Molecules , 25 , (21) .

Advisory Council on the Misuse of Drugs. (2020) Synthetic cannabinoid receptor agonists (SCRA). An updated harms assessment and a review of classification and scheduling under the Misuse of Drugs Act 1971 and its Regulations. London: Advisory Council on the Misuse of Drugs.

Poyatos, Lourdes and Pérez-Acevedo, Ana Pilar and Papaseit, Esther and Pérez-Mañá, Clara and Martin, Soraya and Hladun, Olga and Siles, Adrià and Torrens, Marta and Busardo, Francesco Paolo and Farré, Magí (2020) Oral administration of cannabis and Δ-9-tetrahydrocannabinol (THC) preparations: a systematic review. Medicina , 56 , (6) .

National Institute on Drug Abuse. (2020) DrugFacts: Marijuana concentrates. Bethesda, MD: National Institute on Drug Abuse.

[thejournal.ie] , MacNamee, Garreth Gardaí believe 'incredibly potent' cannabis on Irish streets due to shortages caused by Covid-19. (25 Apr 2020)

National Institute on Drug Abuse. [NIDA] Marijuana research report: What are marijuana's long-term effects on the brain. (08 Apr 2020)

Hindley, Guy and Beck, Katherine and Borgan, Faith and Ginestet, Cedric E and McCutcheon, Robert and Kleinloog, Daniel and Ganesh, Suhas and Radhakrishnan, Rajiv and D'Souza, Deepak Cyril and Howes, Oliver D (2020) Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis. The Lancet Psychiatry , 7 , (4) , pp. 344-353.

Lancet Press Office. (2020) The Lancet Psychiatry: Single dose of psychoactive component in cannabis could induce psychotic, depressive, and anxiety symptoms in healthy people. EurekAlert .

Food Safety Authority. Consumers being put at risk and misled with some CBD food supplements. (13 Feb 2020)

Food Safety Authority. (2020) Survey: regulatory issues with hemp-based food and food supplements on the Irish market. Dublin: Food Safety Authority.

Colizzi, Marco and Weltens, Nathalie and McGuire, Philip and Lythgoe, David and Williams, Steve and van Oudenhove, Lukas and Bhattacharyya, Sagnik (2020) Delta-9-tetrahydrocannabinol increases striatal glutamate levels in healthy individuals: implications for psychosis. Molecular Psychiatry , 25 , pp. 3231-3240.

Volkow, Nora D and Weiss, Susan RB (2020) Importance of a standard unit dose for cannabis research. Addiction , 115 , (7) .

Matsumoto, Toshihiko and Kawabata, Toshitaka and Okita, Kyoji and Tanibuchi, Yuko and Funada, Daisuke and Murakami, Maki and Usami, Takashi and Yokoyama, Rie and Naruse, Nobuya and Aikawa, Yuzo and Furukawa, Aizo and Komatsuzaki, Chie and Hashimoto, Nozomu and Fujita, Osamu and Umemoto, Aiko and Kagaya, Ariyuki and Shimane, Takuya (2020) Risk factors for the onset of dependence and chronic psychosis due to cannabis use: Survey of patients with cannabis-related psychiatric disorders. Neuropsychopharmacology Reports , 40 , (4) , pp. 332-341.

[FSAI Ireland] Recall of EUPHORIA CBD Full Spectrum Oil products due to the presence of THC, an unauthorised substance. (16 Jul 2019)

[Oireachtas] Dail Eireann debate. Questions on promised legislation [Medicinal cannabis]. (12 Jun 2019)

[Oireachtas] Dail Eireann debate. Questions on promised legislation [THC]. (30 May 2019)

Freeman, Tom P and Hindocha, Chandni and Green, Sebastian F and Bloomfield, Michael AP (2019) Medicinal use of cannabis based products and cannabinoids. BMJ (Clinical Research ed.) , 365 , l1141.

Orr, Catherine and Spechler, Philip and Cao, Zhipeng and Albaugh, Matthew and Chaarani, Bader and Mackey, Scott and D'Souza, Deepak and Allgaier, Nicholas and Banaschewski, Tobias and Bokde, Arun L W and Bromberg, Uli and Büchel, Christian and Burke Quinlan, Erin and Conrod, Patricia and Desrivières, Sylvane and Flor, Herta and Frouin, Vincent and Gowland, Penny and Heinz, Andreas and Ittermann, Bernd and Martinot, Jean-Luc and Paillère Martinot, Marie-Laure and Nees, Frauke and Papadopoulos Orfanos, Dimitri and Paus, Tomáš and Poustka, Luise and Millenet, Sabina and Fröhner, Juliane H and Radhakrishnan, Rajiv and Smolka, Michael N and Walter, Henrik and Whelan, Robert and Schumann, Gunter and Potter, Alexandra and Garavan, Hugh (2019) Grey matter volume differences associated with extremely low levels of cannabis use in adolescence. The Journal of Neuroscience , 3375-17 .

Bloomfield, Michael A P and Hindocha, Chandni and Green, Sebastian F and Wall, Matthew B and Lees, Rachel and Petrilli, Katherine and Costello, Harry and Olabisi Ogunbiyi, M and Bossong, Matthijs G and Freeman, Tom P (2019) The neuropsychopharmacology of cannabis: a review of human imaging studies. Pharmacology & Therapeutics , 195 , pp. 132-161.

Di Forti, Marta and Quattrone, Diego and Freeman, Tom P and Tripoli, Giada and Gayer-Anderson, Charlotte and Quigley, Harriet and Rodriguez, Victoria and Jongsma, Hannah E and Ferraro, Laura and La Cascia, Caterina and La Barbera, Daniele and Tarricone, Ilaria and Berardi, Domenico and Szöke, Andrei and Arango, Celso and Tortelli, Andrea and Velthorst, Eva and Bernardo, Miguel and Del-Ben, Cristina Marta and Rossi Menezes, Paulo and Selten, Jean Paul and Jones, Peter B and Kirkbride, James B and Rutten, Bart PF and et al, . (2019) The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. The Lancet Psychiatry , 6 , (5) .

[Oireachtas] Dail Eireann. Leaders questions [Medicinal cannabis]. (06 Dec 2018)

[Oireachtas] Dail Eireann - Leaders' questions [Medicinal cannabis]. (07 Nov 2018)

[Oireachtas] Dail Eireann debate. Questions on promised legislation [Medicinal cannabis]. (27 Jun 2018)

[Independent.ie] , Chazen, David Parisians queue for cannabis as drug laws relaxed. (11 Jun 2018)

[Oireachtas] Dail Eireann debates. Written answer 878 - Cannabis for medicinal use [15907/18]. (17 Apr 2018)

[Oireachtas] Dail Eireann debate. Written answer 484 - question to health [Medicinal cannabis] [9931/18]. (27 Feb 2018)

[Oireachtas] Dail Eireann debates. Written answer 297 - Drug and alcohol testing [driving] [4175/18]. (30 Jan 2018)

[Irish Examiner] , Fegan, Joyce First licence granted to treat pain with cannabis. (18 Nov 2017)

[Oireachtas] Dail Eireann debate. Written answer 290- Cannabis for medicinal use [47744/17]. (14 Nov 2017)

WHO Expert Committee on Drug Dependence. (2017) Cannabidiol (CBD) pre-review report. Agenda item 5.2. Geneva: World Health Organization.

[Oireachtas] Dail Eireann debate. Written Answer 149 - Medicinal products licensing [39974/17]. (21 Sep 2017)

Dillon, Lucy (2017) Cannabis for medical use: a scientific review. Drugnet Ireland , Issue 62, Summer 2017 , pp. 9-10.

Guiney, Ciara (2017) Cannabis legislation in Europe: an overview. Drugnet Ireland , Issue 62, Summer 2017 , pp. 10-11.

Health Products Regulatory Authority. (2017) Cannabis for medical use - a scientific review. Dublin: Department of Health.

Fischer, Benedikt and Russell, Cayley and Sabioni, Pamela and van den Brink, Wim and Le Foll, Bernard and Hall, Wayne and Rehm, Jürgen and Room, Robin (2017) Lower-risk cannabis use guidelines: a comprehensive update of evidence and recommendations. American Journal of Public Health , 107 , (8) , e1-e12.

McGowan, Hugh (2016) The blunt truth: can marijuana fund better healthcare? RCSI Student Medical Journal , 9 , (1) , pp. 100-102.

Barnes, Michael P and Barnes, Jennifer C (2016) Cannabis: the evidence for medical use. London: All-Party Parliamentary Group for Drug Policy Reform.

Dines, Alison M and Wood, David M and Galicia, Miguel and Yates, Christopher M and Heyerdahl, Fridtjof and Hovda, Knut Erik and Giraudon, Isabelle and Sedefov, Roumen and Dargan, Paul I (2015) Presentations to the emergency department following cannabis use--a multi-centre case series from ten European countries. Journal of Medical Toxicology , 11 , (4) , pp. 415-421.

[thejournal.ie] , Ryan, Nicky Skunk is becoming more and more of a problem in Ireland – it is not ‘simply cannabis’. (05 Mar 2015)

(2013) … and the Minister replies. Drugnet Ireland , Issue 46, Summer 2013 , p. 11.

National Centre for Pharmacoeconomics. (2013) Delta-9-tetrahydrocannabinol (THC) /Cannabidiol (CBD) (Sativex®). Dublin: National Centre for Pharmacoeconomics.

Advisory Council on the Misuse of Drugs. (2012) Further consideration of the synthetic cannabinoids. London: Home Office.

Behan, Aine and Hryniewiecka, Magdalena and O'Tuathaigh, Colm MP and Kinsella, Anthony and Cannon, Mary and Karayiorgou, Maria and Gagos, Joseph A and Waddington, John L and Cotter, David R (2012) Chronic adolescent exposure to Delta-9-Tetrahydrocannabinol in COMT mutant mice: impact on indices of dopaminergic, endocannabinoid and GABAergic pathways. Neuropsychopharmacology , 37 , pp. 1773-1783.

Tormey, William P (2012) Cannabis, possible cardiac deaths and the coroner in Ireland. Irish Journal of Medical Science , 181 , (4) , pp. 479-482.

Forensic Science Laboratory. Arnold, Colette (2011) The potency of THC in Cannabis products. Dublin: National Advisory Committee on Drugs.